Finding Description
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, record review, and interview, the facility failed to ensure that residents prescribed antipsychotic medications received appropriate gradual dose reduction (GDR) attempts and failed to provide documented clinical justification for the continued use of the antipsychotic medications for 2 of 5 residents reviewed for unnecessary medications. (Resident 3 and Resident 9) Findings include: 1. During an observation, on 11/19/25 at 3:32 p.m., Resident 3 quietly lay in bed with her eyes closed. During an observation, on 11/20/25 at 8:33 a.m., Resident 3 sat quietly in a Broda (high-backed wheeled reclining) chair in the dining room as she was assisted with eating. During an observation, on 11/20/25 at 12:02 p.m., Resident 3 sat quietly in a Broda chair in the dining room at a table with other residents. During an observation, on 11/21/25 at 11:59 a.m., Resident 3 sat quietly in her Broda chair as CNA 10 propelled her to the dining room. During an observation, on 11/24/25 at 10:20 p.m., Resident 3 quietly lay in bed with her eyes closed. Resident 3's clinical record was reviewed on 11/20/25 at 1:33 p.m. Diagnoses included Alzheimer's disease, neurocognitive disorder with Lewy Bodies, anxiety disorder, major depressive disorder, recurrent, severe with psychotic symptoms, nontraumatic intracerebral hemorrhage in cerebellum, and dementia, unspecified severity, with mood disturbances. Current orders included Abilify (antipsychotic) 2 mg every evening (11/15/24), vilazodone (antidepressant) 40 mg daily (6/21/22), and risperidone (antipsychotic) 1 mg twice a day (11/15/24). A significant change Minimum Data Set (MDS) assessment, dated 10/1/25, indicated the resident was rarely or never understood. She had short- and long-term memory problems. She had severely impaired cognitive skills for daily decision making. She did not exhibit hallucinations or delusions during the assessment period. She did not exhibit physical symptoms directed towards others, verbal symptoms directed toward others, nor behavioral symptoms not directed towards others during the assessment period. She was not resistive to care during the assessment period. She was dependent on staff assistance for her activities of daily living. She received antipsychotic and antidepressant classes of medication. A GDR was clinically contraindicated on 9/5/25. A care plan, initiated and revised on 5/9/23, indicated the resident had the potential to be physically aggressive related to Alzheimer's dementia and neurocognitive disorder with Lewy Bodies as exhibited by hitting, kicking, pushing, and fighting during care. Interventions included the following: Administer medications as ordered. Monitor/document for side effects and effectiveness (5/29/23); Assess and anticipate resident's needs; food, thirst, toileting needs, comfort level, body positioning, pain, etc. (5/9/23); and Communication: provide physical and verbal cues to alleviate anxiety, give positive feedback, assist verbalization of the source of agitation, assist to set goals for more pleasant behavior, encourage seeking out of a staff member when agitated (5/9/23). A care plan, initiated and revised on 5/10/23, indicated the resident had a history of behavior problems related to the neurocognitive disorder with Lewy Bodies as exhibited by physical aggression, visual hallucinations, and bizarre behavior, specifically playing in and eating feces. Interventions included the following: Administer psychotropic medications as ordered. Monitor/document for side effects and effectiveness (5/10/23); Anticipate and meet resident's needs (5/10/23); and Explain all procedures to the resident before starting and allow the resident three to five minutes or more if needed to adjust to changes (5/10/23). A care plan, initiated and revised 5/5/23, indicated the resident used psychotropic medications (risperidone and Abilify) related to behavior management with diagnoses of major depressive disorder, recurrent, severe with psychotic symptoms as exhibited by visual hallucinations, physical aggression, and bizarre behaviors such as playing in and eating stool. Interventions included the following: Administer psychotropic medication as ordered by physician. Monitor for side effects and effectiveness every shift (5/5/23); Consult with the pharmacy, physician to consider dosage reduction when clinically appropriate at least quarterly (5/5/23); and Monitor/record occurrence of target behavior symptoms (wandering, disrobing, playing in and eating stool, violence/aggression towards staff/others, visual hallucinations) and document per facility protocol (5/5/23). A care plan, initiated 5/5/23 and revised 5/8/23, indicated the resident used an antidepressant medication. Interventions included administer antidepressant medications as ordered by the physician and monitor/document side effects and effectiveness every shift (5/5/23). A psychosocial note, dated 7/16/25 at 3:15 p.m., indicated the resident's mood appeared stable with no obvious depressive feelings. She had no behaviors which included no hallucinations, no delusional thinking, no obvious signs of anxiety episodes or other mood issues. The resident received Abilify, risperidone, and vilazodone for symptoms related to major depressive disorder, recurrent, severe with psychotic symptoms. The resident's representative refused the facility's efforts to attempt GDR's of any of the resident's psychoactive medication and do not allow the in-house physician to treat the resident. The resident's family physician treats the resident and declines all recommendations to GDR the resident's psychoactive medications. A plan of care note, dated 8/22/25 at 12:46 p.m., indicated the resident had no reported behaviors. The SSD notified the resident representative of the black box warning for the psychoactive medications. The resident representative indicated the family physician wanted the resident to take these medications. The resident's representative was advised to request a GDR from the physician for the psychoactive medication. The resident no longer experienced symptoms, and the resident's disease process prevented her from performing previously demonstrated behavioral symptoms. An appointment with the family physician was scheduled for 9/5/25. A pharmacy consultation report, dated 8/28/25, provided by the DON on 11/24/25 at 10:45 a.m., indicated the pharmacist commented that the resident received two antipsychotics for major depressive disorder with psychotic symptoms, Abilify 2 mg every evening since 6/27/23 and risperidone 1 mg twice a day since 4/28/23. The pharmacist recommended the resident's Abilify and risperidone be reviewed for a GDR and questioned if the resident was a candidate for a trial dose reduction of either agent, with perhaps a trial off Ability, and if the resident was receiving the lowest effective dose. The physician response, in which he checked a box, indicated he declined the recommendations above because GDR was clinically contraindicated for the resident because continued use was in accordance with the current standard of practice and a GDR attempt at this time was likely to impair the resident's function or cause psychiatric instability by exacerbating an underlying medical condition or psychiatric disorder as documented below. The form had blank lines below the checked statement and did not provide a rationale for the declination of a GDR of the Abilify and risperidone. The physician signed the form on 9/5/25. A physician progress note, dated 9/5/25, indicated the resident was seen for dementia, hypothyroidism, and hypercholesterolemia. The resident's medications were listed with no changes marked. The physician examined the resident. The assessment indicated that the resident's medication list was reconciled and updated, and they will continue to take the medications as listed other than as excepted. The progress note for the resident's physician visit lacked a rationale for declining the GDR for the Abilify and risperidone. A pharmacy consultation report, dated 10/29/25, provided by the DON on 11/25/25 at 10:45 a.m., indicated the pharmacist commented that the resident had received vilazodone 40 mg every day for the management of major depressive disorder since 4/28/23. The pharmacist recommended a GDR of the vilazodone to 20 mg every day. The physician response, in which he checked a box, indicated he declined the recommendations above because GDR was clinically contraindicated for the resident because continued use was in accordance with the current standard of practice and a GDR attempt at this time was likely to impair the resident's function or cause psychiatric instability by exacerbating an underlying medical condition or psychiatric disorder as documented below. The form had blank lines below the checked statement and did not provide a rationale for the declination of a GDR of the vilazodone. The physician signed the form on 11/3/25. During an interview, on 11/21/25 at 11:54 a.m., the SSD indicated behaviors were documented on a behavior sheet. She did not have any behaviors documented for the resident. The resident had been mostly calm since she had admitted to the facility. She had spoken to the resident's representative multiple times about the need to GDR the resident's antipsychotic medications. The resident's representative took the resident out of the facility to the family doctor. Even though the resident had no behaviors, the resident's representative did not want the resident's psychoactive medications reduced or discontinued. During an interview, on 11/21/25 at 11:59 a.m., RN 5 indicated she had spoken to the resident's representative in the past, and she had declined to allow a GDR of the resident's psychoactive medications. The resident was calm all the time. When the resident first arrived at the facility some time ago, she was occasionally tearful. But she had not been tearful for a while. During an interview, on 11/21/25 at 3:03, RN 8 indicated the resident was consistently calm. During an interview, on 11/24/25 at 2:12 p.m., CNA 7 indicated she had no problems at all with the resident having any behaviors. During an interview, on 11/24/25 at 2:35 p.m., the DON indicated she was aware the resident had no behavioral symptoms, but the resident representative and the physician declined to reduce and/or discontinue any of the resident's psychoactive medications. 2. During an observation, on 11/19/25 at 1:00 p.m., Resident 9 sat quietly in his wheelchair in the dining room and fed himself lunch. During an observation, on 11/19/25 at 3:51 p.m., Resident 9 lay quietly in his bed with the head of the bed elevated. His eyes were closed. During an observation, on 11/20/25 at 8:15 a.m., Resident 9 sat quietly in his wheelchair in the dining room and fed himself lunch. During an observation, on 11/20/25 at 10:24 a.m., Resident 9 sat in his room in his wheelchair and repeatedly stated, I need help. LPN 8 talked with resident, and he calmed. During an observation, on 11/20/25 at 12:02 p.m., Resident 9 sat in his wheelchair in the dining room and conversed with a visitor sitting at his table. During an observation, on 11/21/25 at 9:36 a.m., the SSD propelled Resident 9 in his wheelchair down the hall as he sat quietly and looked around. During an observation, on 11/24/25 at 9:57 a.m., Resident 9 sat quietly in his wheelchair at a table in the front lounge area with other residents. Resident 9's clinical record was reviewed on 11/21/25 at 9:16 a.m. Diagnoses included other specified depressive episodes and dementia, moderate, with agitation. Current orders included donepezil (for dementia) 10 mg daily at bedtime (8/4/25), escitalopram (antidepressant) 20 mg daily at bedtime (10/17/25), risperidone (antipsychotic) 1 mg daily at bedtime (10/23/25), quetiapine (antipsychotic) 25 mg twice a day (10/23/25), and tramadol-acetaminophen (for pain) 37.5/325 mg twice a day (8/16/25). A quarterly Minimum Data Set (MDS) assessment, dated 8/4/25, indicated the resident was moderately cognitively impaired. He did not exhibit hallucinations or delusions during the assessment period. He did not exhibit physical symptoms directed towards others, verbal symptoms directed toward others, nor behavioral symptoms not directed towards others during the assessment period. He was not resistive to care during the assessment period. He required supervision/touching assistance of staff with eating. With oral hygiene and rolling in bed, he required substantial/maximal staff assistance. He was dependent on staff assistance for toileting hygiene, showering/bathing, upper/lower body dressing, donning/doffing footwear, personal hygiene, and transfers. He required partial/moderate staff assistance with propelling his manual wheelchair for 50 to 150 feet. He received antipsychotic, antidepressant, and opioid classes of medication. The physician documented a GDR was clinically contraindicated on 11/6/25. A care plan, initiated and revised on 10/20/25, indicated the resident had a behavior problem related to dementia as exhibited by sexually inappropriate remarks, grasping, and agitation with verbal aggression. The interventions included the following: Administer medication as ordered. Monitor/document for side effects and effectiveness (10/20/25); Explain all procedures to the resident before starting and allow the resident time to adjust to changes (10/20/25); and Intervene as necessary to protect the rights and safety of others. Approach/speak in a calm manner. Divert attention. Remove from situation and take to alternate location as needed (10/20/25).A care plan, initiated and revised on 11/19/25, indicated the resident was physically aggressive on occasion including hitting, kicking staff related to dementia, moderate with agitation. The interventions included the following: The resident's triggers for physical aggression are during care specifically during nighttime hours. The resident's behaviors is de-escalated by waking resident gently, explaining procedure before attempting care (11/19/25); Assess and anticipate resident's needs - food, thirst, toileting needs, comfort level, body positioning, pain, etc. (11/19/25); Monitor/document/report as needed any signs or symptoms of resident posing a danger to himself and others (11/19/25); and When the resident becomes agitated: Intervene before agitation escalates. Guide resident away from source of distress. Engage calmly in conversation. If response is aggressive, staff to walk calmly away and approach later (11/19/25). A care plan, initiated 8/7/25 and revised 11/19/25, indicated the resident used psychotropic medications (quetiapine and risperidone) related to behavior management. The diagnosis was dementia, moderate with agitation, and included sexually inappropriate behaviors and combativeness during care. The interventions included the following: Administer psychotropic medications as ordered by physician. Monitor for side effects and effectiveness every shift (8/7/25); Consult with pharmacy, physician to consider dosage reduction when clinically appropriate at least quarterly (8/7/25); and Monitor/record occurrence of target behavior symptoms (inappropriate sexual behavior and language, aggression towards staff/others, etc.) and document per facility protocol (8/7/25). A care plan, initiated and revised 8/7/25, indicated the resident used an antidepressant medication related to depressive disorder. The interventions included: Administer antidepressant medications as ordered by physician. Monitor/document side effects and effectiveness every shift (8/7/25). A psychosocial progress note, dated 8/11/25 at 2:48 p.m., indicated the resident received quetiapine for signs and symptoms related to his dementia with behaviors including sexually inappropriate behaviors. He had a history of inappropriate behaviors prior to his stay in the facility. He had no behaviors, no hallucinations, no delusions, no anxiety and no other mood issues since admission to the facility. A psychosocial progress note, dated 9/2/25 at 10:45 a.m., indicated the SSD met with the resident's representative to discuss the resident's psychotropic medications and the black box warning for quetiapine. The resident's representative indicated the resident was prescribed the medication for inappropriate sexual behaviors at the previous facility. The resident representative declined to have a GDR of the quetiapine attempted because the resident was planned to return to the prior facility to live with his wife. A health status note, dated 9/3/25 at 11:32 a.m., indicated the resident was alert with periods of confusion. He had periods of combativeness which made care difficult at times. A health status note, dated 9/14/25 at 5:31 a.m., indicated the staff attempted to get the resident dressed and up for breakfast. He attempted to grab the CNA's bottom and made several inappropriate remarks. The CNA told the resident the remarks were inappropriate, and the resident said they were not. Then, the resident said he was going to break the CNA's hand. He tried to squeeze and twist the CNA's hand. The CNA removed her hand from the resident's hands and left the room to allow the resident to calm down. A health status note, dated 9/19/25 at 6:25 a.m., indicated the staff performed morning care when the resident threatened to knock out the staff's teeth. He drew his fist back and yelled for the staff to put some clothes on him. The staff were attempting to put clothing on him. A psychosocial note, dated 9/29/25 at 3:27 p.m., indicated a care plan meeting was held with the resident's representatives. The resident was no longer progressing in therapy and continued to require a mechanical lift for transfers. The consensus of the resident's representatives, therapy, and nursing was that resident would be unable to return to an assisted living facility. A health status note, dated 10/12/25 at 6:03 p.m., indicated the resident was agitated throughout much of the day, which was out of character for him. He was confused and yelled out throughout the day. A health status note, dated 10/14/25 at 6:03 a.m., indicated the resident became combative with staff during morning care. He attempted to hit and kick staff. A psychosocial note, dated 10/15/25 at 4:07 p.m., indicated the resident was to remain in the facility with no discharge plans. A health status note, dated 10/16/25 at 11:59 p.m., indicated the physician increased the resident's escitalopram medication from 10 mg to 20 mg daily. A behavior note, dated 10/17/25 at 6:32 a.m., indicated the resident was on his roommate's side of the room. The resident threatened to knock the roommate's head off. He had his fist drawn back and refused to leave. The staff assisted the resident from the room. A psychosocial note, dated 10/17/25 at 11:02 a.m., indicated the resident did not recall threatening or yelling at his roommate. The resident was moved to another room. The resident representative indicated the resident's behavior was out of character for him. A Behavior Referral form, dated 10/23/25 at 5: 15 a.m., provided by the SSD on 11/21/25 at 12:15 p.m., indicated the resident's behaviors observed were verbal abuse, physical abuse, and resistance to care. The resident needed incontinence care. The behavior was semi existing as he went from verbal to physical behaviors. The staff provided incontinence care. When the resident was rolled, he yelled, cursed, and threatened staff. The staff explained to the resident he needed changed and to get ready for the day. Staff waited, went back, and pulled up the resident's brief. The resident punched the staff in the arm several times. The staff moved away from resident. The resident grabbed the staff and attempted to pull the staff into bed. The staff covered the resident with a sheet and left the room. A health status note, dated 10/23/25 at 5:19 a.m., indicated when a male staff member began to dress and turn the resident in bed, the resident hit the staff member in the arm and tried to drag the staff member closer to the resident. The staff member walked away from the resident. The Director of Nursing (DON) was notified. A health status note, dated 10/23/25 at 1:33 p.m., indicated the physician came to the facility and ordered risperidone 1mg at bedtime and increased the resident's quetiapine from 25 mg daily to 25 mg twice a day. Labs were ordered. A physician's progress note, dated 10/23/25, indicated the physician saw the resident for an acute visit regarding behaviors. He performed a review of systems and a physical assessment. He indicated the resident was positive for agitation and behavioral symptoms. His assessment and plan was to increase the quetiapine and add risperidone to the resident medication regimen. The notes lacked additional rationale for the changes in the resident's psychotropic medications. A health status note, dated 10/25/25 at 6:11 a.m., indicated the resident became combative with morning care. He cussed and told the staff he was going to knock their heads off. He swung his fist back and attempted to hit the staff. A health status note, dated 10/27/25 at 4:34 p.m., indicated no new orders were received related to the resident's recent lab results. The resident appeared to be agitated. A pharmacy consultation report, dated 10/29/25, provided by the DON on 11/24/25 at 10:45 a.m., indicated the pharmacist commented the resident received two or more antipsychotics which included risperidone 1 mg every bedtime and quetiapine 25 mg twice a day. Evidence for the use of multiple antipsychotics was limited and increased the risk for drug interactions, medication errors, and cumulative side effects. His recommendation was to consider discontinuing quetiapine and consider adding a morning dose of risperidone if the resident's behaviors increased after the quetiapine was discontinued. On 11/6/25, the physician indicated he had re-evaluated the therapy and did not wish to implement any changes due to the resident was stable on his current medications. A change would be disruptive to the resident care and potentially harmful. A Behavior Referral form, dated 11/10/25 at 7:30 a.m., provided by the SSD on 11/21/25 at 12:15 p.m., indicated the resident's behaviors observed were verbal abuse, physical abuse, and resistance to care. The resident was asked to do a task and needed incontinence care. A female staff member provided incontinence care. A male staff member heard the resident yelling and cursing. The male staff member attempted to explain to the resident they were helping him, and he was dirty. During incontinence care, the resident yelled, kicked, and swung his arms. The staff quickly put resident's brief on him, covered him, and left the room. A Behavior Referral form, dated 11/14/25 at 3:30 a.m., provided by the SSD on 11/21/25 at 12:15 p.m., indicated the resident's behaviors observed were verbal abuse and physical abuse. The resident needed incontinence care. The staff attempted to provide incontinence care, and the resident stated What the he** are you doing? Staff told the resident they needed to change him because his brief was wet. The resident hit, pulled at the staff's hands, and kicked at staff. The staff left the room for a moment then returned. The resident continued to hit staff during the incontinence care. A psychosocial note, dated 11/14/25 at 9:07 a.m., indicated the resident became combative during incontinence care. The staff left the room and returned, but the resident remained resistant and combative, such as hitting and kicking at staff. During an interview, on 11/20/25 at 3:23 p.m., CNA 6 indicated she had never had any problems providing care for the resident. He was very sweet. During an interview, on 11/21/25 at 2:59 p.m., RN 8 indicated the resident got mad and yelled if incontinence care was not done fast enough. The resident gradually started swinging at the staff, and it was not consistent behavior. The yelling though was common. He had improved since his family member had recently moved to the facility. During an interview, on 11/24/25 at 2:12 p.m., CNA 7 indicated she had no difficulties providing the resident's care. She just had to give him a few minutes to wake up and tell him what she was going to do then he was fine. During an interview, on 11/24/25 at 2:26 p.m., the DON indicated she had not seen the resident's behaviors but heard he grabbed and pushed at the staff. She was uncertain if the behaviors were psychotic behaviors or dementia behaviors, but his behaviors had improved since the medications had been changed. During an interview on 11/24/25 at 3:27 p.m., the SSD indicated she had received no additional behavioral referrals for Resident 9 other than the three she had provided. The black box warning for risperidone was retrieved on 11/24/25 from the FDA website at www.accessdata.fda.gov/drugsatfda_docs/label/2009/020272s056,020588s044,021346s033,021444s03lbl.pdf. The guidance indicated .WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS .Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. The indications for use for risperidone include the following: schizophrenia, bipolar mania, and irritability associated with autistic disorder in children and adolescents aged 5 to [AGE] years old. The black box warning for quetiapine was retrieved on 11/24/25 from the FDA website at www.accessdata.fda.gov/drugsatfda_docs/label/2020/020639s069lbl.pdf. The guidance indicated .WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS .Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. The indications for use for quetiapine included schizophrenia, bipolar I disorder manic episodes, and bipolar disorder, depressive episodes. A current facility policy, dated 12/31/24, titled Tapering Medications and Gradual Drug Dose Reduction, provided by the DON on 11/24/25 at 3:00 p.m., indicated the following: .Residents who use antipsychotic drugs shall receive gradual dose reductions and behavioral interventions, unless clinically contraindicated, in an effort to discontinue these drugs.For any individual who is receiving an antipsychotic medication to treat behavioral symptoms related to dementia, the GDR may be considered clinically contraindicated if: a. The resident's target symptoms returned or worsened after the most recent attempt at a GDR within the facility; and b. The physician has documented the clinical rationale for why any additional attempted dose reduction at that time would be likely to impair the resident's function or increase distressed behavior. A current facility policy, dated 12/31/24, titled Antipsychotic Medication Use, provided by the DON on 11/24/25 at 3:00 p.m., indicated the following: .Residents will only receive antipsychotic medications when necessary to treat specific conditions for which they are indicated and effective.Antipsychotic medication shall generally be used only for the following conditions/diagnoses as documented in the record consistent with the definition(s) in the Diagnostic and Statistical Manual of Mental Disorders (current or subsequent editions): a. Schizophrenia; b. Schizo-affective disorder; c. Schizophreniform disorder; d. Delusional disorder; e. Mood disorders (e.g. bipolar disorder, depression with psychotic features, and treatment refractory major depression); f. Psychosis in the absence or presence of dementia: g. Medical illnesses with psychotic symptoms and/or treatment-related psychosis or mania (e.g., high-dose steroids); h. Tourette's Disorder; i. Huntington Disease; j. Hiccups (not induced by other medications); or k. Nausea and vomiting associated with cancer or chemotherapy.Diagnoses alone do not warrant the use of antipsychotic medications. In addition to the above criteria, antipsychotic medications will generally only be considered if the following conditions are also met: a. The behavioral symptoms present a danger to the resident and others; AND; (1) The symptoms are identified as being due to mania or psychosis (such as auditory, visual, or other hallucinations; delusions, paranoia or grandiosity); or (2) Behavioral interventions have been attempted and included in the plan of care, except in an emergency.The Physician shall respond appropriately by changing or stopping problematic doses or medications, or clearly documenting (based on assessing the situation) why the benefits of the medication outweigh the risks or suspected or confirmed adverse consequences. 3.1-48(a)(4)3.1-48(b)(2)